Antiepileptogenic effect of curcumin on kainate-induced model of temporal lobe epilepsy

Pharmaceutical Biology

Volumn 51, Issue 12, 2013, Pages 1572-1578

  Kiasalari, Zahra ^a   Roghani, Mehrdad ^a   Khalili, Mohsen ^a   Rahmati, Batool ^a   Baluchnejadmojarad, Tourandokht ^b  

^a SHAHED UNIVERSITY   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Malondialdehyde; Neurodegeneration; Neuroprotective; Nitrite and nitrate; Seizure; Superoxide dismutase; Turmeric

Indexed keywords

CURCUMIN; KAINIC ACID; MALONALDEHYDE; NITRATE; NITRITE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ANTIEPILEPTOGENIC EFFECT; ARTICLE; BRAIN LEVEL; BRAIN NERVE CELL; CONTROLLED STUDY; DENTATE HILUS; DISEASE ACTIVITY; ENZYME ACTIVITY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HISTOCHEMISTRY; MALE; MOSSY FIBER; MOSSY FIBER SPROUTING; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; SEIZURE; TEMPORAL LOBE EPILEPSY;

ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; CURCUMIN; DISEASE MODELS, ANIMAL; EPILEPSY, TEMPORAL LOBE; HIPPOCAMPUS; KAINIC ACID; MALE; NEUROPROTECTIVE AGENTS; NITRITES; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 84886709656     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.803128     Document Type: Article

References (54)

1. Acharya MM, Hattiangady B, Shetty AK. (2008). Progress in neuroprotective strategies for preventing epilepsy. Prog Neurobiol 84:363-404.
2. Agarwal NB, Jain S, Agarwal NK, et al. (2011). Modulation of pentylenetetrazole-induced kindling and oxidative stress by curcumin in mice. Phytomedicine 18:756-9.
3. Agrawal SS, Gullaiya S, Dubey V, et al. (2012). Neurodegenerative shielding by curcumin and its derivatives on brain lesions induced by 6-OHDA model of Parkinson's disease in albino Wistar rats. Cardiovasc Psychiatry Neurol 2012:942981.
4. Akarsu ES, Ozdayi S, Algan E, Ulupinar F. (2006). The neuronal excitability time-dependently changes after lipopolysaccharide administration in mice: Possible role of cyclooxygenase-2 induction. Epilepsy Res 71:181-7.
5. Bala K, Tripathy BC, Sharma D. (2006). Neuroprotective and antiageing effects of curcumin in aged rat brain regions. Biogerontology 7: 81-9.
6. Baluchnejadmojarad T, Roghani M. (2011). Chronic epigallocatechin-3- gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress. Behav Brain Res 224: 305-10.
7. Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 72:248-54.
8. Canales-Aguirre AA, Gomez-Pinedo UA, Luquin S, et al. (2012). Curcumin protects against the oxidative damage induced by the pesticide parathion in the hippocampus of the rat brain. Nutr Neurosci 15:62-9.
9. Ciceri P, Zhang Y, Shaffer AF, et al. (2002). Pharmacology of celecoxib in rat brain after kainate administration. J Pharmacol Exp Ther 302: 846-52.
10. Crespo-Biel N, Camins A, Canudas AM, Pallas M. (2010). Kainateinduced toxicity in the hippocampus: Potential role of lithium. Bipolar Disord 12:425-36.
11. Dhir A, Naidu PS, Kulkarni SK. (2006). Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action. Prog Neuropsychopharmacol Biol Psychiatry 30:1478-85.
12. Dichter MA. (2006). Models of epileptogenesis in adult animals available for antiepileptogenesis drug screening. Epilepsy Res 68: 31-5.
13. Ezz HS, Khadrawy YA, Noor NA. (2011). The neuroprotective effect of curcumin and Nigella sativa oil against oxidative stress in the pilocarpine model of epilepsy: A comparison with valproate. Neurochem Res 36:2195-204.
14. Freitas RM, Vasconcelos SM, Souza FC, et al. (2005). Oxidative stress in the hippocampus after pilocarpine-induced status epilepticus in Wistar rats. FEBS J 272:1307-12.
15. Garcia-Alloza M, Borrelli LA, Rozkalne A, et al. (2007). Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102:1095-104.
16. Gupta YK, Briyal S, Sharma M. (2009). Protective effect of curcumin against kainic acid induced seizures and oxidative stress in rats. Indian J Physiol Pharmacol 53:39-46.
17. Huang HC, Chang P, Dai XL, Jiang ZF. (2012). Protective effects of curcumin on amyloid-beta-induced neuronal oxidative damage. Neurochem Res 37:1584-97.
18. Jokeit H, Schacher M. (2004). Neuropsychological aspects of type of epilepsy and etiological factors in adults. Epilepsy Behav 5: S14-20.
19. Jourquin J, Tremblay E, Decanis N, et al. (2003). Neuronal activitydependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur J Neurosci 18:1507-17.
20. Kang SM, Cha SH, Ko JY, et al. (2012). Neuroprotective effects of phlorotannins isolated from a brown alga, Ecklonia cava, against H2O2-induced oxidative stress in murine hippocampal HT22 cells. Environ Toxicol Pharmacol 34:96-105.
21. Karoly N, Mihaly A, Dobo E. (2011). Comparative immunohistochemistry of synaptic markers in the rodent hippocampus in pilocarpine epilepsy. Acta Histochem 113:656-62.
22. Li SY, Jia YH, Sun WG, et al. (2010). Stabilization of mitochondrial function by tetramethylpyrazine protects against kainate-induced oxidative lesions in the rat hippocampus. Free Radic Biol Med 48: 597-608.
23. Lin MS, Sun YY, Chiu WT, et al. (2011). Curcumin attenuates the expression and secretion of RANTES after spinal cord injury in vivo and lipopolysaccharide-induced astrocyte reactivation in vitro. J Neurotrauma 28:1259-69.
24. Liu K, Peterson KL, Raboy V. (2007). Comparison of the phosphorus and mineral concentrations in bran and abraded kernel fractions of a normal barley (Hordeum vulgare) cultivar versus four low phytic acid isolines. J Agric Food Chem 55:4453-60.
25. Liu SH, Chang CD, Chen PH, et al. (2012). Docosahexaenoic acid and phosphatidylserine supplementations improve antioxidant activities and cognitive functions of the developing brain on pentylenetetrazolinduced seizure model. Brain Res 1451:19-26.
26. Loscher W. (2002). Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 50:105-23.
27. Loscher W, Schmidt D. (2006). New horizons in the development of antiepileptic drugs: Innovative strategies. Epilepsy Res 69:183-272.
28. Majores M, Eils J, Wiestler OD, Becker AJ. (2004). Molecular profiling of temporal lobe epilepsy: Comparison of data from human tissue samples and animal models. Epilepsy Res 60:173-8.
29. Mansouri Z, Sabetkasaei M, Moradi F, et al. (2012). Curcumin has neuroprotection effect on homocysteine rat model of Parkinson. J Mol Neurosci 47:234-42.
30. Matteucci A, Frank C, Domenici MR, et al. (2005). Curcumin treatment protects rat retinal neurons against excitotoxicity: Effect on N-methyl-D-Aspartate-induced intracellular Ca(2) increase. Exp Brain Res 167: 641-8.
31. Mattson MP, Kater SB. (1989). Development and selective neurodegeneration in cell cultures from different hippocampal regions. Brain Res 490:110-25.
32. Mythri RB, Bharath MM. (2012). Curcumin: A potential neuroprotective agent in Parkinson's disease. Curr Pharm Des 18:91-9.
33. Naziroglu M, Kutluhan S, Uguz AC, et al. (2009). Topiramate and vitamin e modulate the electroencephalographic records, brain microsomal and blood antioxidant redox system in pentylentetrazolinduced seizure of rats. J Membr Biol 229:131-40.
34. Noor NA, Aboul Ezz HS, Faraag AR, Khadrawy YA. (2012). Evaluation of the antiepileptic effect of curcumin and Nigella sativa oil in the pilocarpine model of epilepsy in comparison with valproate. Epilepsy Behav 24:199-206.
35. Ochiishi T, Saitoh Y, Yukawa A, et al. (1999). High level of adenosine A1 receptor-like immunoreactivity in the CA2/CA3a region of the adult rat hippocampus. Neuroscience 93:955-67.
36. Paxinos G, Watson C. (1986). The Rat Brain in Stereotaxic Coordinates. 2nd ed. San Diego (CA): Academic Press.
37. Racine R, Okujava V, Chipashvili S. (1972). Modification of seizure activity by electrical stimulation. 3. Mechanisms. Electroencephalogr Clin Neurophysiol 32:295-9.
38. Reeta KH, Mehla J, Pahuja M, Gupta YK. (2011). Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats. Pharmacol Biochem Behav 99:399-407.
39. Roghani M, Baluchnejadmojarad T. (2009). Chronic epigallocatechingallate improves aortic reactivity of diabetic rats: Underlying mechanisms. Vascul Pharmacol 51:84-9.
40. Sharma AK, Reams RY, Jordan WH, et al. (2007). Mesial temporal lobe epilepsy: Pathogenesis, induced rodent models and lesions. Toxicol Pathol 35:984-99.
41. Shetty AK, Hattiangady B. (2007). Restoration of calbindin after fetal hippocampal CA3 cell grafting into the injured hippocampus in a rat model of temporal lobe epilepsy. Hippocampus 17:943-56.
42. Shin HJ, Lee JY, Son E, et al. (2007). Curcumin attenuates the kainic acid-induced hippocampal cell death in the mice. Neurosci Lett 416: 49-54.
43. Sood PK, Nahar U, Nehru B. (2012). Stress proteins and glial cell functions during chronic aluminium exposures: Protective role of curcumin. Neurochem Res 37:639-46.
44. Sperk G. (1994). Kainic acid seizures in the rat. Prog Neurobiol 42:1-32.
45. Stefan H, Lopes da Silva FH, Loscher W, et al. (2006). Epileptogenesis and rational therapeutic strategies. Acta Neurol Scand 113:139-55.
46. Tiwari V, Chopra K. (2012). Attenuation of oxidative stress, neuroinflammation, and apoptosis by curcumin prevents cognitive deficits in rats postnatally exposed to ethanol. Psychopharmacology (Berl) 224: 519-35.
47. Tripanichkul W, Jaroensuppaperch EO. (2012). Curcumin protects nigrostriatal dopaminergic neurons and reduces glial activation in 6-hydroxydopamine hemiparkinsonian mice model. Int J Neurosci 122: 263-70.
48. Verrotti A, Scardapane A, Franzoni E, et al. (2008). Increased oxidative stress in epileptic children treated with valproic acid. Epilepsy Res 78: 171-7.
49. Waldbaum S, Patel M. (2010). Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res 88:23-45.
50. Weber LP, Chow WL, Abebe W, MacLeod KM. (1996). Enhanced contractile responses of arteries from streptozotocin diabetic rats to sodium fluoride. Br J Pharmacol 118:115-22.
51. Wu Z, Xu Q, Zhang L, et al. (2009). Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem Res 34:1393-400.
52. Yang F, Lim GP, Begum AN, et al. (2005). Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280:5892-901.
53. Young D, Dragunow M. (1995). Neuronal injury following electrically induced status epilepticus with and without adenosine receptor antagonism. Exp Neurol 133:125-37.
54. Yu S, Zheng W, Xin N, et al. (2010). Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-Terminal kinase pathway. Rejuvenation Res 13:55-64.